Guardant Health Inc

11 de set. de 2026, 20:08 UTC

Guardant Health Inc shares are lower today, continuing a trend since Thursday's close. The stock is trading below its 20-day moving average.

10 de set. de 2026, 20:07 UTC

Guardant Health Inc shares are lower today, reflecting broader market declines. The stock peaked earlier but has since reached a session low.

8 de set. de 2026, 20:08 UTC

Guardant Health recognized by Business Insider for innovation in biotechnology. Shares are lower today, pulling back from earlier session highs.

4 de set. de 2026, 20:02 UTC

Guardant Health Inc shares are lower today, extending a decline over three sessions. High trading volume accompanies the move amid unchanged unemployment data.

2 de set. de 2026, 20:08 UTC

Guardant Health Inc shares are lower today, following a session high earlier. The decline coincides with a disappointing ADP employment report.

1 de set. de 2026, 20:03 UTC

Guardant Health shares are higher as Carelon Health Services will cover its Shield blood test for colorectal cancer screening starting November 15, expanding access to 90 million lives.

31 de ago. de 2026, 20:07 UTC

Guardant Health Inc shares are lower today, continuing a trend from recent sessions amid broader market concerns over inflation and potential interest rate hikes.

28 de ago. de 2026, 23:16 UTC

Guardant Health Inc shares are lower in after-market hours, continuing a trend of declines amid rising Treasury yields impacting technology stocks.

26 de ago. de 2026, 20:08 UTC

Guardant Health Inc shares are higher, reflecting a broader market trend since Tuesday. U.S. inflation data showed slightly higher-than-expected consumer price increases.

25 de ago. de 2026, 19:36 UTC

A federal court ruled against Guardant Health, awarding $83.4 million to TwinStrand BioSciences. Despite this, shares are higher during Tuesday's session.

24 de ago. de 2026, 22:16 UTC

A federal court upheld an $83.4 million award against Guardant Health for patent infringement, though shares are trading higher in after-market hours.

21 de ago. de 2026, 19:16 UTC

Guardant Health Inc shares are higher today, despite pulling back from an intraday high. The stock remains well above its 20-day moving average.

20 de ago. de 2026, 23:46 UTC

Guardant Health Inc. shares advanced in after-market trading, remaining above their 20-day moving average amid broader market pressures from rising crude oil prices.

19 de ago. de 2026, 20:02 UTC

Guardant Health Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average and near recent highs.

14 de ago. de 2026, 19:36 UTC

Guardant Health Inc shares are lower amid broader market sentiment following disappointing retail sales data, which may impact consumer demand and Federal Reserve interest rate policy.

13 de ago. de 2026, 23:36 UTC

Guardant Health shares are higher in after-market trading, though no specific news was identified. Broader market sentiment may be influenced by unchanged producer prices.

12 de ago. de 2026, 19:51 UTC

Guardant Health shares are lower as insider sales raise investor concerns. Director Ian Clark sold 14,180 shares for $2.3 million earlier this month.

10 de ago. de 2026, 19:36 UTC

Guardant Health Inc. shares are higher today, remaining above their 20-day moving average amid rising oil prices driven by geopolitical tensions.

7 de ago. de 2026, 20:03 UTC

Guardant Health Inc shares are advancing amid strong momentum and high trading volume. Broader market gains coincide with a decline in Treasury yields.

6 de ago. de 2026, 19:36 UTC

Guardant Health Inc shares are lower today, continuing a decline since Wednesday's close. No specific news was identified to explain the movement.

3 de ago. de 2026, 19:56 UTC

Guardant Health shares are higher as Stifel and Canaccord maintain Buy ratings, raising price targets to $180 and $205, respectively.

31 de jul. de 2026, 19:51 UTC

Guardant Health Inc shares are trading higher as analysts raise price targets following strong second-quarter results and an upward revision of full-year revenue guidance.

30 de jul. de 2026, 23:21 UTC

Guardant Health reported second-quarter revenue of $335 million, raising 2026 guidance to $1.34 billion to $1.36 billion, boosting shares in after-market hours.

29 de jul. de 2026, 18:54 UTC

Guardant Health Inc shares are higher as investors anticipate Q2 earnings on Thursday, following last quarter's revenue of $301.7 million, up 48.3% year-over-year.

28 de jul. de 2026, 19:16 UTC

Guardant Health shares are lower despite a tribute video featuring Patrick Dempsey and RBC's note on potential coverage tailwinds for the company.

27 de jul. de 2026, 19:36 UTC

Guardant Health Inc shares are lower, continuing a five-day decline despite a 48% year-over-year revenue increase and strong performance in the Shield segment.

24 de jul. de 2026, 18:36 UTC

Guardant Health Inc shares are lower today, continuing a decline since Thursday's close and remaining below the 20-day moving average.

20 de jul. de 2026, 20:02 UTC

Guardant Health Inc shares are lower today, continuing a decline since Friday amid mixed U.S. market performance and ongoing geopolitical tensions impacting investor sentiment.